12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Aclarion (ACON) saw a 70% increase, while TRACON Pharma (TCON) rose by 47.92%. Eterna Therapeutics (ERNA) and Passage Bio (PASG) also gained, with increases of 22.8% and 21.23%, respectively. Conversely, bluebird bio (BLUE) dropped by 51.9%, and other companies like Jin Medical International (ZJYL), argenx (ARGX), and Xilio Therapeutics (XLO) saw declines ranging from 17.89% to 30.63%.
December 21, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
argenx shares decreased by 24.68% to $340.9, with a market value of $20.1 billion.
A 24.68% pre-market decline is a significant negative development that could lead to further short-term depreciation in argenx's stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
bluebird bio shares plummeted by 51.9% to $1.17, with a market cap of $128.0 million.
A sharp decline of 51.9% in pre-market trading is a strong negative indicator that could result in continued downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Xilio Therapeutics stock decreased by 17.89% to $0.49, with a market cap of $13.5 million.
The pre-market decline of 17.89% could suggest a bearish outlook for Xilio Therapeutics in the short term, potentially leading to further losses.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Jin Medical International stock fell by 30.63% to $79.0, with a market cap of $612.2 million.
The significant pre-market drop of 30.63% could indicate negative sentiment that may persist in the short term, affecting the stock price negatively.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Aclarion shares surged 70% to $0.49 with a market value of $4.6 million.
A significant pre-market gain of 70% is likely to attract investor attention and could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Eterna Therapeutics stock increased by 22.8% to $1.87, with a market value of $10.0 million.
A 22.8% pre-market increase is a positive signal that could lead to further short-term gains as the market opens.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Passage Bio shares rose by 21.23% to $0.92, with a market value of $50.4 million.
The pre-market gain of 21.23% for Passage Bio could continue to drive the stock upward in the short term as the market responds.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
TRACON Pharma shares increased by 47.92% to $0.28, with a market cap of $8.6 million.
The substantial pre-market rise of 47.92% indicates strong investor interest which may lead to further short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100